Soslow RA, Kong CS, Brenton JD, Malpica A, Davidson B, Soerjomataram I, Folkin AK, Vang R. Tomours of the ovary; High-grade serous carcinoma of the ovary. In: WHO Classification of Tumours Editorial Board. Female Genital Tumours. WHO classification of tumours. 5th ed. Lyon: IARC Press; 2020. pp.45–47.
da Cunha Colombo Bonadio RR, Fogace RN, Miranda VC, Diz MDPE. Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management. Clinics (Sao Paulo). 2018;73:e450s.
Kekeeva T, Dudina I, Andreeva Y, Tanas A, Kalinkin A, Musatova V, et al. Molecular subgroups of HRD positive ovarian cancer and their prognostic significance. Int J Mol Sci. 2024;25:13549.
Article CAS PubMed PubMed Central Google Scholar
Liu H, Zhang Z, Chen L, Pang J, Wu H, Liang Z. Next-generation sequencing reveals a very low prevalence of deleterious mutations of homologous recombination repair genes and homologous recombination deficiency in ovarian clear cell carcinoma. Front Oncol. 2021;11: 798173.
Article CAS PubMed Google Scholar
Gorringe KL, Cheasley D, Wakefield MJ, Ryland GL, Allan PE, Alsop K, et al. Therapeutic options for mucinous ovarian carcinoma. Gynecol Oncol. 2020;156:552–60.
Article CAS PubMed PubMed Central Google Scholar
Li HM, Qiang JW, Xia GL, Zhao SH, Ma FH, Cai SQ, et al. MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma. J Ovarian Res. 2015;8:26.
Article PubMed PubMed Central Google Scholar
Ma F-H, Qiang J-W, Zhang G-F, Li H-M, Cai S-Q, Rao Y-M. Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma. J Ovarian Res. 2016;9:40.
Article PubMed PubMed Central Google Scholar
Saida T, Shikama A, Mori K, Ishiguro T, Minaguchi T, Satoh T, et al. Comparing characteristics of pelvic high-grade serous carcinomas with and without breast cancer gene variants on MR imaging. Magn Reson Med Sci. 2024;23:18–26.
Article CAS PubMed Google Scholar
Takeyama N, Sasaki Y, Ueda Y, Tashiro Y, Tanaka E, Nagai K, et al. Magnetic resonance imaging-based radiomics analysis of the differential diagnosis of ovarian clear cell carcinoma and endometrioid carcinoma: a retrospective study. Jpn J Radiol. 2024;42:731–43.
Article PubMed PubMed Central Google Scholar
Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401–7.
Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med. 2005;53:1432–40.
Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A, Guerra A, Fournier LS, Stojanovic S, et al. Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. JAMA Netw Open. 2020;3: e1919896.
Article PubMed PubMed Central Google Scholar
Hindman N, Kang S, Fournier L, Lakhman Y, Nougaret S, Reinhold C, et al. MRI evaluation of uterine masses for risk of leiomyosarcoma: A consensus statement. Radiology. 2023;306: e211658.
Aoyagi T, Shuto K, Okazumi S, Hayano K, Satoh A, Saitoh H, et al. Apparent diffusion coefficient correlation with oesophageal tumour stroma and angiogenesis. Eur Radiol. 2012;22:1172–7.
Alshuhri MS, Alhulail AA, Alqahtani AGM, Madkhali Y, Aljuhani M, Alghuraybi RA, et al. Stability of ADC measurements in diffusion MRI: A multicenter phantom study using multi-point b-values. Radiography (Lond). 2025;31:212–9.
Article CAS PubMed Google Scholar
Woo S, Lee JM, Yoon JH, Joo I, Han JK, Choi BI. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. Radiology. 2014;270:758–67.
Lee YJ, Kim SH, Kang BJ, Kang YJ, Yoo H, Yoo J, et al. Intravoxel incoherent motion (IVIM)-derived parameters in diffusion-weighted MRI: Associations with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging. 2017;45:1394–406.
Yuan M, Pu X-H, Xu X-Q, Zhang Y-D, Zhong Y, Li H, et al. Lung adenocarcinoma: Assessment of epidermal growth factor receptor mutation status based on extended models of diffusion-weighted image. J Magn Reson Imaging. 2017;46:281–9.
Yuan M, Zhong Y, Zhang Y-D, Yu T-F, Li H, Wu J-F. Volumetric analysis of intravoxel incoherent motion imaging for assessment of solitary pulmonary lesions. Acta Radiol. 2017;58:1448–56.
Zhang Y-D, Wang Q, Wu C-J, Wang X-N, Zhang J, Liu H, et al. The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the gleason grade of prostate cancer. Eur Radiol. 2015;25:994–1004.
Ai Z, Han Q, Huang Z, Wu J, Xiang Z. The value of multiparametric histogram features based on intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) for the differential diagnosis of liver lesions. Ann Transl Med. 2020;8:1128.
Article PubMed PubMed Central Google Scholar
Koh D-M, Collins DJ, Orton MR. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol. 2011;196:1351–61.
Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168:497–505.
Luo M, Zhang L, Jiang XH, Zhang WD. Intravoxel incoherent motion: application in differentiation of hepatocellular carcinoma and focal nodular hyperplasia. Diagn Interv Radiol. 2017;23:263–71.
Article PubMed PubMed Central Google Scholar
Le Bihan D, Turner R. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med. 1992;27:171–8.
Guo W, Luo D, Lin M, Wu B, Li L, Zhao Y, et al. Pretreatment intra-voxel incoherent motion diffusion-weighted imaging (IVIM-DWI) in predicting induction chemotherapy response in locally advanced hypopharyngeal carcinoma. Medicine (Baltimore). 2016;95: e3039.
Someya Y, Iima M, Imai H, Isoda H, Ohno T, Kataoka M, et al. In vivo and post-mortem comparisons of IVIM/time-dependent diffusion MR imaging parameters in melanoma and breast cancer xenograft models. Magn Reson Med Sci [Internet]. 2024; Available from: https://doi.org/10.2463/mrms.mp.2023-0078
Song X-L, Wang L, Ren H, Wei R, Ren J-L, Niu J. Intravoxel incoherent motion imaging in differentiation borderline from malignant ovarian epithelial tumors: Correlation with histological cell proliferation and vessel characteristics. J Magn Reson Imaging. 2020;51:928–35.
Wang F, Wang Y, Zhou Y, Liu C, Xie L, Zhou Z, et al. Comparison between types I and II epithelial ovarian cancer using histogram analysis of monoexponential, biexponential, and stretched-exponential diffusion models. J Magn Reson Imaging. 2017;46:1797–809.
Li HM, Zhao SH, Qiang JW, Zhang GF, Feng F, Ma FH, et al. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression. J Magn Reson Imaging. 2017;46:1499–506.
Andreou A, Koh DM, Collins DJ, Blackledge M, Wallace T, Leach MO, et al. Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol. 2013;23:428–34.
Article CAS PubMed Google Scholar
Maiuro A, Di Stadio F, Palombo M, Ciardiello A, Satta S, Pernazza A, et al. Endometrial cancer tissue features clusterization by kurtosis MRI. Med Phys [Internet]. 2025; Available from: https://pubmed.ncbi.nlm.nih.gov/40018821/
Köbel M, Bennett JA, Cheung AN, DeLair DF, Kiyokawa T, Shih I. Tomours of the ovary; Clear cell carcinoma of the ovary. In: WHO Classification of Tumours Editorial Board. Female Genital Tumours. WHO classification of tumours. 5th ed. Lyon: IARC Press; 2020. pp.58–61.
Köbel M, Huntsman DG, Lim D, McCluggage WG, Rabban JT, Shih I. Tomours of the ovary; Endometrioid carcinoma of the ovary. In: WHO Classification of Tumours Editorial Board. Female Genital Tumours. WHO classification of tumours. 5th ed. Lyon: IARC Press; 2020. pp.65–67.
Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch. 2012;460:237–49.
Itamochi H, Kigawa J, Sugiyama T, Kikuchi Y, Suzuki M, Terakawa N. Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstet Gynecol. 2002;100:281–7.
Deen SS, Priest AN, McLean MA, Gill AB, Brodie C, Crawford R, et al. Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer. Sci Rep. 2019;9:10742.
Comments (0)